Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
302.11
-6.40 (-2.07%)
At close: Apr 28, 2026, 4:00 PM EDT
306.99
+4.88 (1.62%)
After-hours: Apr 28, 2026, 7:41 PM EDT
Alnylam Pharmaceuticals Analyst Ratings
Total Analysts
28
Consensus Rating
Strong Buy
Price Target
$471.00
Upside
+55.90%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $515 → $505 | Strong Buy | Maintains | $515 → $505 | +67.16% | Apr 13, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $425 | Strong Buy | Maintains | $425 | +40.68% | Mar 25, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $510 | Strong Buy | Reiterates | $510 | +68.81% | Mar 25, 2026 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $522 → $330 | Strong Buy → Hold | Downgrades | $522 → $330 | +9.23% | Mar 16, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $510 | Strong Buy | Reiterates | $510 | +68.81% | Feb 18, 2026 |
| Freedom Broker | Freedom Broker | Hold → Strong Buy Upgrades $470 → $410 | Hold → Strong Buy | Upgrades | $470 → $410 | +35.71% | Feb 17, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $415 → $429 | Strong Buy | Maintains | $415 → $429 | +42.00% | Feb 17, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $475 → $425 | Strong Buy | Maintains | $475 → $425 | +40.68% | Feb 13, 2026 |
| Needham | Needham | Strong Buy Maintains $529 → $510 | Strong Buy | Maintains | $529 → $510 | +68.81% | Feb 12, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $495 → $408 | Hold | Maintains | $495 → $408 | +35.05% | Jan 30, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $529 → $462 | Strong Buy | Maintains | $529 → $462 | +52.92% | Jan 30, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $570 → $510 | Strong Buy | Maintains | $570 → $510 | +68.81% | Jan 30, 2026 |
| Barclays | Barclays | Buy Initiates $527 | Buy | Initiates | $527 | +74.44% | Jan 28, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $500 → $465 | Buy | Maintains | $500 → $465 | +53.92% | Jan 20, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $479 → $376 | Hold | Maintains | $479 → $376 | +24.46% | Jan 20, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $530 → $529 | Strong Buy | Maintains | $530 → $529 | +75.10% | Jan 12, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.